Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|November 4, 2014
[Drug-induced interstitial lung diseases]Philippe Bonniaud, Marjolaine Georges, Nicolas Favrolt, et al.
Respiratory Medicine Case Reports|November 7, 2022
Hemorrhage in a patient with Bronchial Dieulafoy's disease and associated pulmonary fibrosis: A case reportPierre Tankeré, Nicolas Favrolt, Sophie Yavordios, et al.
ERJ Open Research|September 17, 2025
Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide studyPierre Tankéré, Emilie Lajeune, Anne-Sophie Mariet, et al.
The European Respiratory Journal|January 26, 2020
Familial pulmonary arterial hypertension by <i>KDR</i> heterozygous loss of functionMélanie Eyries, David Montani, Barbara Girerd, et al.
Respiratory Medicine and Research|January 11, 2023
Endobronchial valves: 1st Multicenter retrospective study on the 2-step approachThomas Egenod, Nicolas Guibert, Yoann Ammar, et al.
The Clinical Respiratory Journal|January 21, 2016
Endobronchial metastases from melanoma: a survival analysisAmandine Chaussende, Christophe Hermant, Rachid Tazi-Mezalek, et al.
ERJ Open Research|May 21, 2024
Characteristics and outcomes of gemcitabine-associated pulmonary hypertensionPierre Mouillot, Nicolas Favrolt, Charles Khouri, et al.
Chest|November 21, 2024
Association of Pulmonary Hypertension With Trastuzumab Emtansine: An Analysis of French Pulmonary Hypertension Registry and WHO Pharmacovigilance DatabaseCamille Poisson, Alex Hlavaty, Nicolas Favrolt, et al.
Chest|September 26, 2020
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin CMarie-Caroline Certain, Marie-Camille Chaumais, Xavier Jaïs, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
Pageof 3